title: Clinical methods for the detection and management of left ventricular hypertrophy.
abstract: Left ventricular hypertrophy (LVH) has been shown to be an independent risk factor for adverse cardiac and cerebrovascular events. Despite this well-known association, the lack of a standardized approach for both the quantification of LVH and the monitoring of LVH regression has limited its use as a primary risk factor that can be clinically targeted. In this State of the Art Paper, we will provide a current appraisal of LVH with a focus on presenting the current methods to accurately detect LVH and management strategies to develop a therapeutic target for clinicians.
authors.affiliation: University of Chicago Medical Center, South Maryland Avenue, Chicago, USA.
authors.forename: Rajiv S
authors.initials: RS
authors.lastname: Swamy
authors.forename: Roberto M
authors.initials: RM
authors.lastname: Lang
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001794:Blood Pressure; D006352:Heart Ventricles / Q000503:physiopathology*; D006801:Humans; D006973:Hypertension / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D017379:Hypertrophy, Left Ventricular / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology; D011379:Prognosis; D012307:Risk Factors
chemical_list: D000959:Antihypertensive Agents